(VIANEWS) – SELVAAG BOLIG (SBO.OL), ABN AMRO BANK N.V. (ABN.AS), SPAREBANKEN ØST (SPOG.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SELVAAG BOLIG (SBO.OL)
133% sales growth and 10.32% return on equity
Selvaag Bolig ASA, a housing development company, engages in the development, construction, and sale of residential properties in Greater Oslo, Bergen, Stavanger, Trondheim, and Stockholm. The company also offers project management services. Selvaag Bolig ASA was incorporated in 2008 and is headquartered in Oslo, Norway. Selvaag Bolig ASA is a subsidiary of Selvaag AS.
Earnings Per Share
As for profitability, SELVAAG BOLIG has a trailing twelve months EPS of kr2.58.
PE Ratio
SELVAAG BOLIG has a trailing twelve months price to earnings ratio of 11.09. Meaning, the purchaser of the share is investing kr11.09 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.32%.
Yearly Top and Bottom Value
SELVAAG BOLIG’s stock is valued at kr28.60 at 16:20 EST, way below its 52-week high of kr39.85 and higher than its 52-week low of kr27.10.
Volume
Today’s last reported volume for SELVAAG BOLIG is 29600 which is 43.28% below its average volume of 52190.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Aug 15, 2023, the estimated forward annual dividend rate is 3 and the estimated forward annual dividend yield is 11.07%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 82.4% and positive 318.7% for the next.
More news about SELVAAG BOLIG.
2. ABN AMRO BANK N.V. (ABN.AS)
16.8% sales growth and 10.93% return on equity
ABN AMRO Bank N.V. provides various banking products and services to retail, private, and business clients in the Netherlands and internationally. It operates through three segments: Personal & Business Banking, Wealth Management, and Corporate Banking. The company provides savings and deposits products; labelled residential mortgage products under the Florius brands; and consumer loans under the Alpha Credit Nederland, Credivance, Defam, Moneyou, and ABN AMRO brands. It also issues, promotes, manages, and processes credit cards; provides revolving credit card facilities and pension schemes, as well as consumer credit and mortgages; and life and non-life insurance products. In addition, it offers asset-based solutions, including working capital solutions, equipment leases and loans, and vendor lease services; private banking and wealth-management-related services; and derivatives and equity clearing services. ABN AMRO Bank N.V. was incorporated in 2009 and is headquartered in Amsterdam, the Netherlands.
Earnings Per Share
As for profitability, ABN AMRO BANK N.V. has a trailing twelve months EPS of €2.71.
PE Ratio
ABN AMRO BANK N.V. has a trailing twelve months price to earnings ratio of 4.82. Meaning, the purchaser of the share is investing €4.82 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.93%.
Yearly Top and Bottom Value
ABN AMRO BANK N.V.’s stock is valued at €13.06 at 16:20 EST, way below its 52-week high of €17.00 and way above its 52-week low of €10.40.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 21.3% and positive 35.1% for the next.
Sales Growth
ABN AMRO BANK N.V.’s sales growth is 15.9% for the ongoing quarter and 16.8% for the next.
Volume
Today’s last reported volume for ABN AMRO BANK N.V. is 962060 which is 68.8% below its average volume of 3084370.
More news about ABN AMRO BANK N.V..
3. SPAREBANKEN ØST (SPOG.OL)
11.3% sales growth and 7.72% return on equity
Sparebanken Øst operates as a savings bank in Eastern Norway. The company offers financial products, such as savings, credit, and payment products; current accounts; home mortgage loans; and mortgage loans for new and used cars. It also provides vehicles, houses and contents, boats, and leisure insurance products, as well as life and health insurance products; and shares and funds trading services. In addition, the company buys, sells, and stores cryptocurrencies, as well as operates, manages, leases, and sells real estate properties. The company was founded in 1843 and is headquartered in Drammen, Norway.
Earnings Per Share
As for profitability, SPAREBANKEN ØST has a trailing twelve months EPS of kr6.35.
PE Ratio
SPAREBANKEN ØST has a trailing twelve months price to earnings ratio of 7.54. Meaning, the purchaser of the share is investing kr7.54 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.72%.
Moving Average
SPAREBANKEN ØST’s worth is above its 50-day moving average of kr47.38 and above its 200-day moving average of kr47.46.
Sales Growth
SPAREBANKEN ØST’s sales growth is 31% for the current quarter and 11.3% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 77.2% and 16.3%, respectively.
More news about SPAREBANKEN ØST.
4. SPAREBANKEN MØRE (MORG.OL)
6% sales growth and 11.3% return on equity
Sparebanken Møre, together with its subsidiaries, provides banking services for retail and corporate customers in Norway. It operates through Retail and Real Estate Brokerage segments. The company offers services in the areas of financing, deposits and other forms of investments, payment transfers, financial advisory services, asset management, insurance, and real estate brokerage. Sparebanken Møre was founded in 1843 and is headquartered in Ålesund, Norway.
Earnings Per Share
As for profitability, SPAREBANKEN MØRE has a trailing twelve months EPS of kr16.8.
PE Ratio
SPAREBANKEN MØRE has a trailing twelve months price to earnings ratio of 4.58. Meaning, the purchaser of the share is investing kr4.58 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.3%.
Sales Growth
SPAREBANKEN MØRE’s sales growth is 30% for the ongoing quarter and 6% for the next.
Volume
Today’s last reported volume for SPAREBANKEN MØRE is 102463 which is 491% above its average volume of 17337.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 40.7% and 0.9%, respectively.
More news about SPAREBANKEN MØRE.
5. MEDISTIM (MEDI.OL)
5.8% sales growth and 32.37% return on equity
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, MEDISTIM has a trailing twelve months EPS of kr6.41.
PE Ratio
MEDISTIM has a trailing twelve months price to earnings ratio of 32.76. Meaning, the purchaser of the share is investing kr32.76 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.37%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MEDISTIM’s EBITDA is 7.26.
Yearly Top and Bottom Value
MEDISTIM’s stock is valued at kr210.00 at 16:20 EST, way under its 52-week high of kr312.50 and way above its 52-week low of kr170.50.
More news about MEDISTIM.
